Automated Breast Ultrasound Systems Market - By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By End-use (Hospitals, Diagnostic Imaging Centres, Specialty Centres)- Global Forecast to 2032

Automated Breast Ultrasound Systems Market Size

Automated Breast Ultrasound Systems Market size was worth USD 1.7 billion in 2022. Driven by the rising prevalence of breast cancer globally, the industry could grow at 15.5% CAGR from 2023 to 2032.
 

Adoption of a sedentary lifestyle, coupled with excessive smoking and alcohol intake, has given birth to diseases such as breast cancer. According to CDC, around 264,000 cases of breast cancer in women and nearly 2,400 in men are reported every year in the U.S. alone. The commendable rise in disease burden has favored the adoption of ABUS for the early detection of the condition, eventually contributing to global market expansion.
 

Moreover, favorable government initiatives for spreading awareness about the diagnosis and treatment of breast cancer are further creating a notable impetus for industry growth. For instance, in Australia, the National Breast Cancer Foundation, Inc. considers October as breast cancer awareness month every year. It aims to create awareness and impart knowledge about the early detection and prevention of breast cancer among women.
 

COVID-19 Impact

The automated breast ultrasound systems market faced numerous consequences of the COVID-19 pandemic due to subsequent supply chain halts caused by prolonged lockdowns. The viral outbreak caused the cancellation and postponement of non-essential breast cancer screenings and elective surgeries, including mastectomy and lumpectomy. Additionally, the healthcare resources went into reducing infection rates, posing major challenges to the installation of new equipment for breast cancer screening. However, consolidated efforts by the government and healthcare organizations toward restoring diagnostic procedural volume will present lucrative opportunities for market growth in the post-pandemic era. 
 

Automated Breast Ultrasound Systems Market Trends

Technological breakthroughs focused on developing novel automated breast ultrasound systems will generate abundant opportunities for market growth. Computer-aided detection (CAD) systems are now being integrated with ABUS to further assist radiologists in detecting and characterizing breast lesions. Fusion imaging, which combines ABUS images with other imaging modalities, such as mammography or magnetic resonance imaging (MRI), is being employed to provide a more comprehensive evaluation of breast abnormalities.
 

Automated Breast Ultrasound Systems Market Analysis

Based on the product, the ABUS market size will reach USD 4.5 billion by 2032. Recent advancements in ABUS have led to a reduction in the duration of cancer diagnosis. Modern ABUS systems utilize advanced transducer technology to acquire three-dimensional images of the entire breast. This three-dimensional imaging capability allows for a more comprehensive assessment of the breast tissue, improving visualization and aiding breast ultrasound for detecting and characterizing abnormalities.
 

Regarding end-use, the hospitals segment amassed around 45% of the automated breast ultrasound systems market share in 2022. Commendable rise in breast cancer-related hospitalizations has increased the utilization of ABUS systems in hospitals. Hospital facilities are equipped with advanced diagnostic tools that help detect the disease accurately in less time. Moreover, the high availability of skilled healthcare professionals in these facilities has increased patient footfalls, supplementing segment progression.
 

North America automated breast ultrasound systems market accumulated 20% of the business revenue in 2022. Growing healthcare spending in the region is supporting industry growth. In May 2022, the U.S. Department of Health and Human Services announced the availability of USD 5 million for community health centers to increase access to cancer screenings. Moreover, the growing prevalence of breast cancer has further bolstered the adoption of automated breast ultrasound systems in the region. 
 

Automated Breast Ultrasound Systems Market Share

• GE Healthcare
• Metritrack, Inc
• SonoCine, Inc.
• Theraclion
• Koninklijke Philips N.V.
• QView Medical Inc.
• Supersonic Imagine
• Siemens AG

   

Automated Breast Ultrasound Systems Industry News:

• In February 2023, iSono Health, a medical technology company, inked a distribution agreement with Abdul Latif Jameel Health to launch the company’s 3D ultrasound portable breast imaging scanner in the Middle East & Africa. This agreement will help the company extend its geographical footprint while strengthening its brand image. 
   
• In May 2022, THERACLION, a medical device company, unveiled the launch of SONOVEIN® HD. This new technology integrates extracorporeal therapeutic ultrasound solutions and imaging capabilities from SuperSonic Imagine. This launch will offer growth pathways to the company. 
   

The automated breast ultrasound systems market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product

• Automated Breast Ultrasound System (ABUS)
• Automated Breast Volume Scanner (ABVS)
• Others

By End-use

• Hospitals
• Diagnostic imaging centers
• Specialty centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Others
• Asia Pacific
  • China
  • India
  • Japan
  • Thailand
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Others
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Others